Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
/Free Sign Up
 Investing Pro 0
💎 Reveal Undervalued Stocks Hiding in Any Market Get Started
Close

Genmab (GMAB)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
2,589.0 +17.0    +0.66%
15:59:59 - Closed. Currency in DKK ( Disclaimer )
  • Volume: 87,551
  • Bid/Ask: 0.0 / 0.0
  • Day's Range: 2,564.0 - 2,596.0
Type:  Equity
Market:  Denmark
ISIN:  DK0010272202 
S/N:  65985932
Genmab 2,589.0 +17.0 +0.66%

GMAB Balance Sheet

 
Assess the latest Genmab balance sheet. Review the company's financial position, assess their current assets, liabilities and shareholder equity across the most recent periods (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Collapse All
Period Ending: 2022
31/12
 2022
30/09
 2022
30/06
 2022
31/03
Total Current Assets 28377 28739 25491 23175
Cash and Short Term Investments 22324 23788 21615 19988
Cash - - - -
Cash & Equivalents 9893 10377 9816 9071
Short Term Investments 12431 13411 11799 10917
Total Receivables, Net 6053 4951 3876 3187
Accounts Receivables - Trade, Net 5910 4951 3876 2846
Total Inventory - - - -
Prepaid Expenses - - - -
Other Current Assets, Total - - - -
Total Assets 30278 30686 27476 24914
Property/Plant/Equipment, Total - Net 1322 1289 1238 975
Property/Plant/Equipment, Total - Gross 1817 - - -
Accumulated Depreciation, Total -495 - - -
Goodwill, Net - - - -
Intangibles, Net 146 200 216 234
Long Term Investments 133 155 201 239
Note Receivable - Long Term 143 - - 341
Other Long Term Assets, Total - - - 264
Other Assets, Total 6678 8763 8253 8021
Total Current Liabilities 1823 2988 1944 1339
Accounts Payable - - - -
Payable/Accrued - - - -
Accrued Expenses - - - -
Notes Payable/Short Term Debt - - - -
Current Port. of LT Debt/Capital Leases 74 79 80 60
Other Current liabilities, Total 1749 2909 1864 1279
Total Liabilities 2837 4029 2994 2195
Total Long Term Debt 523 550 554 356
Long Term Debt - - - -
Capital Lease Obligations 523 550 554 356
Deferred Income Tax - - - -
Minority Interest - - - -
Other Liabilities, Total 491 491 496 500
Total Equity 27441 26657 24482 22719
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 66 66 66 66
Additional Paid-In Capital 12309 12141 12063 12044
Retained Earnings (Accumulated Deficit) 14968 14299 12243 10512
Treasury Stock - Common - - - -
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 98 151 110 97
Total Liabilities & Shareholders' Equity 30278 30686 27476 24914
Total Common Shares Outstanding 65.37 65.23 65.4 65.49
Total Preferred Shares Outstanding - - - -
* In Millions of DKK (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

GMAB Comments

Write your thoughts about Genmab
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email